Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LifeStance Health GroupLFST +1.23%54 Capex-to-Operating-Income is 0.39 as of Jun. 2026, which is 68% below its 10-year median of 1.22. GuruFocus rates LFST with a GF Score™ of 54/100 and a GF Value™ of $8.59 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 348 Healthcare Providers & Services companies, LifeStance Health Group ranks worse than 52.3% on this metric.
Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.
LifeStance Health Group (NAS:LFST) Capex-to-Operating-Income Explanation
Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.
LifeStance Health Group Capex-to-Operating-Income Related Terms
LifeStance Health Group Capex-to-Operating-Income Historical Data
* Premium members only.
The historical data trend for LifeStance Health Group's Capex-to-Operating-Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeStance Health Group Capex-to-Operating-Income Chart
LFST vs CON, BKD, NHC: Capex-to-Operating-Income Comparison
For the Medical Care Facilities subindustry, LifeStance Health Group's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeStance Health Group Capex-to-Operating-Income vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LifeStance Health Group's Capex-to-Operating-Income distribution charts can be found below:
* The bar in red indicates where LifeStance Health Group's Capex-to-Operating-Income falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Capex-to-Operating-Income of 0.39 mean?
LifeStance Health Group (LFST) has a Capex-to-Operating-Income of 0.39 as of Jun. 2026. Capex to Operating Income ratio measures a company's investments in physical assets to its operating income. View historical data on LifeStance Health Group and its competitors. This is 68% below median its historical median of 1.22. Over the past decade, LifeStance Health Group's Capex-to-Operating-Income has ranged from 0.56 to 1.50. According to the industry distribution chart, LifeStance Health Group ranks #182 out of 348 companies in the Healthcare Providers & Services industry, placing it in the top 52.3%.
Is LifeStance Health Group's Capex-to-Operating-Income too high?
LifeStance Health Group's current Capex-to-Operating-Income of 0.39 is 68% below median its 10-year median of 1.22. Over the past 10 years, this metric has ranged from a low of 0.56 to a high of 1.50. The Healthcare Providers & Services industry median Capex-to-Operating-Income is 0.52. LifeStance Health Group's value of 0.39 is 25% below this industry median. Based on the distribution chart, LifeStance Health Group ranks #182 out of 348 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, LifeStance Health Group has a GF Score™ of 54/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LifeStance Health Group's Capex-to-Operating-Income compare to CON and BKD?
According to the Healthcare Providers & Services industry distribution chart, LifeStance Health Group ranks #182 out of 348 companies for Capex-to-Operating-Income. This places LifeStance Health Group in the lower half of its industry. The industry median Capex-to-Operating-Income is 0.52. LifeStance Health Group's value of 0.39 is 25% below this benchmark. Historically, LifeStance Health Group's own Capex-to-Operating-Income has ranged from 0.56 to 1.50 over the past decade. While the company's 10-year median is 1.22 vs. the industry median of 0.52, LifeStance Health Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Capex-to-Operating-Income for a Healthcare Providers & Services company?
The median Capex-to-Operating-Income among Healthcare Providers & Services companies is 0.52, based on 348 companies in the industry. Companies in the top quartile (top 25%) have a Capex-to-Operating-Income significantly above this median, while those in the bottom quartile fall well below. However, Capex-to-Operating-Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeStance Health Group's current Capex-to-Operating-Income of 0.39 is 25% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Capex-to-Operating-Income mean?
A high Capex-to-Operating-Income can signal that a stock is expensive relative to its fundamentals. Capex to Operating Income ratio measures a company's investments in physical assets to its operating income. View historical data on LifeStance Health Group and its competitors. For the Healthcare Providers & Services industry, the median Capex-to-Operating-Income is 0.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeStance Health Group's current Capex-to-Operating-Income is 0.39, which is 68% below median its own 10-year median of 1.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeStance Health Group stock overvalued right now?
Based on GuruFocus' analysis, LifeStance Health Group (LFST) is currently considered Significantly Overvalued. The stock's GF Value™ is $8.59, compared to a current price of $12.30 — trading 43.2% above its estimated fair value. The current Capex-to-Operating-Income is 0.39, which is 68% below median its 10-year median of 1.22 and 25% below the Healthcare Providers & Services industry median of 0.52. LifeStance Health Group's overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Capex-to-Operating-Income calculated?
Capex-to-Operating-Income is calculated from a company's financial statements. For LifeStance Health Group (LFST), the current Capex-to-Operating-Income is 0.39 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeStance Health Group (LFST) Overvalued in 2026?
Based on GuruFocus' analysis, LifeStance Health Group stock appears to be overvalued.
The current stock price of $12.30 is trading 43.2% above its estimated GF Value™ of $8.59.
GuruFocus considers LifeStance Health Group to be Significantly Overvalued.
Key valuation signals for LFST:
Capex-to-Operating-Income: 0.39 (68% below median its 10-year median of 1.22)
GF Value™: $8.59 vs. price of $12.30 (43.2% above fair value)
Industry Position: 25% below the Healthcare Providers & Services median (#182 of 348)
No single metric tells the full story. See the LFST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
54GF Score
Get the complete analysis for LFST
Capex-to-Operating-Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFST has been successfully added to your 
